Future inhaled drugs by virtual innovation: Allergen delivery inhibitors

Future Medicinal Chemistry

Volumn 3, Issue 13, 2011, Pages 1567-1570

  Robinson, Clive ^a   Zhang, Jihui ^a   Garrod, David R ^b   Newton, Gary K ^c   Jenkins, Kerry ^c   Perrior, Trevor R ^c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Domainex Ltd   (United Kingdom)

Author keywords

allergen delivery inhibitor; allergic rhinitis; asthma; bronchodilator; chronic obstructive pulmonary disease; corticosteroid; house dust mite; inhalation therapy

Indexed keywords

ALLERGEN; ANTIASTHMATIC AGENT; BECLOMETHASONE PLUS FORMOTEROL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; HOUSE DUST ALLERGEN; MUSCARINIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; DRUG STABILITY; HUMAN; PRIORITY JOURNAL; REVIEW; RHINITIS; THERMOSTABILITY;

ADMINISTRATION, INHALATION; ALLERGENS; ANTI-ALLERGIC AGENTS; HUMANS; RESPIRATORY TRACT DISEASES;

EID: 80053188670     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.11.107     Document Type: Review

References (9)

1. Business Insights Ltd. The Asthma, COPD and Allergic Rhinitis Market Outlook to 2015. 1-104 (2010).
2. Cruz AA, Popov T, Pawankar R et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy 62(Suppl. 84) 1-41 (2007). (Pubitemid 47556484)
3. Danielsson J, Jessen M. The natural course of allergic rhinitis during 12 years of follow-up. Allergy 52, 331-334 (1997). (Pubitemid 27166236)
4. Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J. Allergy Clin. Immunol. 109, 419-425 (2002). (Pubitemid 34234190)
5. Stewart GA, Zhang J, Robinson C. The structure and function of allergens. In: Middleton's Allergy. Principles and Practice. Adkinson NF, Bochner BS, Busse WW, Holgate ST, Lemanske RF, Simons FER (Eds).Mosby, PA, USA 569-608 (2009).
6. Asokananthan N, Graham PT, Stewart DJ et al. House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1. J. Immunol. 169, 4572-4578 (2002). (Pubitemid 35178236)
7. Pichavant M, Charbonnier AS, Taront S et al. Asthmatic bronchial epithelium activated by the proteolytic allergen Der p 1 increases selective dendritic cell recruitment. J. Allergy Clin. Immunol. 115, 771-778 (2005). (Pubitemid 40460852)
8. Brown A, Farmer K, MacDonald L et al. House dust mite Der p 1 downregulates defenses of the lung by inactivating elastase inhibitors. Am. J. Respir. Cell Mol. Biol. 29, 381-389 (2003). (Pubitemid 37093997)
9. Deb R, Shakib F, Reid K, Clark H. Major house dust mite allergens Dermatophagoides pteronyssinus 1 and Dermatophagoides farinae 1 degrade and inactivate lung surfactant proteins A and D. J. Biol. Chem. 282, 36808-36819 (2007).